Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
He is one of the founders of ProQR, but even long before that Gerard Platenburg was involved in the development of RNA therapies. Even so, after decades of working on them he still gets enthusiastic when talking about RNA.
There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan joined in 2013, she was only employee number six. As a result, she has seen the company grow and develop.
Bart Klein was at the forefront of ProQR's Axiomer® RNA editing technology development. This platform technology makes it possible to use the cells own machinery to reverse mutations that cause a genetic disease. Read the interview.
… ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10 … only by market approval of QR-110. Innovation credit (“Innovatiekrediet”) The Innovation Credit is awarded by the …
… ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision … at the 7th Annual Retinal Cell and Gene Therapy Innovation Summit being held Friday, April 29, 2022 and the … U.S. Presentations at the Retinal Cell and Gene Therapy Innovation Summit Presentation title: AON treatment for …
